Heyu Biological Technology Corporation
Heyu Biological Technology Corporation (HYBT) Revenue
Annual & quarterly revenue history · segment & region breakdown
HYBT · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsHeyu Biological Technology Corporation trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Heyu Biological Technology Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Heyu Biological Technology Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Heyu Biological Technology Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HYBT revenue · 4 questionsHYBT's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Heyu Biological Technology Corporation SEC filings · GAAP · Heyu Biological Technology Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026